PR Newswire: news distribution, targeting and monitoring

See more news releases in: Food & Beverages, Domestic Policy

 

FDA Seizes More Than $32,000 Worth of Bulk Honey From Philadelphia Distribution Center

 

Agency acts after finding potent antibiotic in bulk honey

SILVER SPRING, Md., June 10 /PRNewswire-USNewswire/ -- At the request of the Food and Drug Administration, federal marshals seized 64 drums of imported bee's honey from a Philadelphia distribution center on June 4 because it contained a potent antibiotic that could lead to serious illness or death.

(Logo:  http://photos.prnewswire.com/prnh/20090824/FDALOGO )

The seizure occurred at the Delaware Avenue Distribution Center, 700 Pattison Avenue, in Philadelphia. The bulk honey was imported by Sweet Works Inc., of Monterey Park, California from Cheng Du Wai Yuan Bee Products Company Limited of Chengdu, China.  Subsequently, it was sold to Alfred L. Wolff Inc. of Chicago, which placed it in storage.

The FDA estimates the value of the seized goods to be more than $32,000. U.S. Marshals executed this seizure pursuant to a warrant issued by the U.S. District Court for the Eastern District of Pennsylvania. The honey is adulterated within the meaning of 21 U.S.C. 342(a)(2)(C) of the federal Food, Drug & Cosmetic Act, because it contains an unsafe food additive.

FDA testing of a sample of this product at the storage facility showed that it contained chloramphenicol, which is not approved for use in food, animal feed, or food-producing animals in the United States.

Chloramphenicol is a potent antibiotic drug that is approved only for use in humans with serious infections when other less toxic drugs won't work. People who are sensitive to chloramphenicol can develop a type of bone marrow depression called aplastic anemia, which can be fatal. 

"Unapproved food additives in the U.S. food supply are of significant concern to the agency," said Michael Chappell, the FDA's acting associate commissioner for regulatory affairs. "The FDA took this action because of the potential serious public health effects of this product."

The FDA is now in the process of inventorying the seized goods.

This case is being investigated by FDA Philadelphia District with the assistance of the U.S. Marshals Service. 

Media Inquiries: Elaine Gansz Bobo, 301-796-7567, elaine.bobo@fda.hhs.gov

Consumer Inquiries: 888-INFO-FDA



SOURCE U.S. Food and Drug Administration

Back to top

RELATED LINKS
http://www.fda.gov/

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.

Featured Video

 
  • Print
  • Email
  •   RSS
  • Share it  
  • Blog it  
  • Blog Search  

Journalists and Bloggers

Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.

View and download archived video content distributed by MultiVu on The Digital Center.

Free Investing Newsletter from Investor Uprising!

Learn to navigate the world's financial system and profit from leading companies.  

Register for Investor Uprising, the people's investment site, for a free weekly newsletter, information, education and premium research including our latest IU Confidential Report - "All That Glitters: The Ultimate Gold Report".

Advanced Search
Search
  
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire